Seattle, WA, United States of America

James L Bachman

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Gilead Sciences, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James L Bachman. Retrieved from https://idiyas.com/inventor/james-l-bachman-3r5ws6n3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of James L Bachman

James L Bachman is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of pharmaceuticals, particularly with his work on KHK inhibitors. His innovative approach has led to the development of compounds that are defined by specific variable substituents, showcasing his expertise in medicinal chemistry.

Latest Patents

James L Bachman holds one patent related to KHK inhibitors. This patent focuses on compounds that have the potential to impact therapeutic strategies in various medical conditions. The precise formulation and application of these compounds highlight his commitment to advancing healthcare solutions.

Career Highlights

Bachman is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company known for its focus on innovative therapies. His role at Gilead allows him to work on cutting-edge research and development projects that aim to improve patient outcomes. His contributions to the company reflect his dedication to scientific advancement and innovation.

Collaborations

James L Bachman collaborates with esteemed colleagues such as Daniel H Byun and Christopher T Clark. These partnerships enhance the research environment and foster the exchange of ideas, which is crucial for driving innovation in the pharmaceutical industry.

Conclusion

In summary, James L Bachman is a prominent inventor whose work on KHK inhibitors has the potential to make a significant impact in the field of medicine. His career at Gilead Sciences, Inc. and collaborations with other talented professionals further underscore his contributions to innovation and healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…